MedTrace Logo

Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at Cesarean

NCT01477840 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2011-12-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether the effect of sublingual misoprostol is better than infusion oxytocin in reduction of blood loss at cesarean deliveries.

Conditions

  • Bleeding Intraoperative

Interventions

DRUG

Misoprostol

Sublingual Misoprostol 200 Micrograms After Spinal Anesthesia

Sponsors & Collaborators

  • Kermanshah University of Medical Sciences

    collaborator OTHER

  • Soudabeh Eshghi ali

    lead OTHER

Principal Investigators

  • Anisodowleh Nankali, MD · Kermanshah University of Medical Sciences

Study Design

Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477840 on ClinicalTrials.gov